Close

Can-Fite BioPharma (CANF) Announces Publication of New CF102 Data in Molecular Medicine Report

Go back to Can-Fite BioPharma (CANF) Announces Publication of New CF102 Data in Molecular Medicine Report

Can-Fite Reports New Data on CF102's Liver Protective & Regenerative Properties Published in Scientific Journal

September 20, 2016 7:01 AM EDT

PETACH TIKVA, Israel, Sept. 20, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs... More